Liquid Biopsy: One-stop-shop for identifying circulating tumor cells using PCR or immunostaining

WIENER NEUSTADT, Austria - Jan. 13, 2021 - PRLog -- The power of liquid biopsy for identifying circulating tumor cells can now be harnessed for the first time with one supplier only that offers the entire range of diagnostic methods. As of today, PCR-based tests as well as immunostaining tests are available at one single company with many years of experience in developing diagnostics for oncology and other medical indications: OncoLab Diagnostics of Wiener Neustadt (Austria), a world-wide specialist for Blood-based Biopsy tests. The company regularly develops patent-protected tests in-house and recently boosted its developing power by joining forces with Axon Dx, a US-based specialist for scanning optical systems powered by artificial intelligence. Products are available for both, research use only (RUO) and in-vitro diagnostic (CE-IVD).

So far, no single supplier across the world has offered tests for both technologies. Now the Austrian company OncoLab Diagnostics GmbH changes that with an extensive range of products for BBBs based on both technologies.

Contact

Prof. Robert Zeillinger, Dr.phil.

OncoLab Diagnostics GmbH

Viktor Kaplan-Str. 2, Objekt E

2700 Wiener Neustadt, Austria

T:  +43 2622 32913-60

M: +43 664 4240373

F.  +43 2622 32913-99

W: https://www.oncolab.at